journal article·2014-11Open access

Key role of the expression of bone morphogenetic proteins in increasing the osteogenic activity of osteoblast-like cells exposed to shock waves and seeded on bioactive glass-ceramic scaffolds for bone tissue engineering

Giuliana Muzio, Germana Martinasso, Francesco Baino, Roberto Frairia, Chiara Vitale-Brovarone, Rosa A Canuto

Abstract

In this work, the role of shock wave-induced increase of bone morphogenetic proteins in modulating the osteogenic properties of osteoblast-like cells seeded on a bioactive scaffold was investigated using gremlin as a bone morphogenetic protein antagonist. Bone-like glass-ceramic scaffolds, based on a silicate experimental bioactive glass developed at the Politecnico di Torino, were produced by the sponge replication method and used as porous substrates for cell culture. Human MG-63 cells, exposed to shock waves and seeded on the scaffolds, were treated with gremlin every two days and analysed after 20 days for the expression of osteoblast differentiation markers. Shock waves have been shown to induce osteogenic activity mediated by increased expression of alkaline phosphatase, osteocalcin, type I collagen, BMP-4 and BMP-7. Cells exposed to shock waves plus gremlin showed increased growth in comparison with cells treated with shock waves alone and, conversely, mRNA contents of alkaline phosphatase and osteocalcin were significantly lower. Therefore, the shock wave-mediated increased expression of bone morphogenetic protein in MG-63 cells seeded on the scaffolds is essential in improving osteogenic activity; blocking bone morphogenetic protein via gremlin completely prevents the increase of alkaline phosphatase and osteocalcin. The results confirmed that the combination of glass-ceramic scaffolds and shock waves exposure could be used to significantly improve osteogenesis opening new perspectives for bone regenerative medicine.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy

Institute of Materials Physics and Engineering, Department of Applied Science and Technology, Politecnico di Torino, Turin, Italy

Department of Medical Sciences, University of Turin, Turin, Italy

References (45)

Show source-provided references
1. 10.1001/archsurg.134.11.118410.1001/archsurg.134.11.1184 ↗
2. 10.1016/S1369-7021(08)70087-710.1016/S1369-7021(08)70087-7 ↗
3. 10.1007/s00441-011-1243-110.1007/s00441-011-1243-1 ↗
4. 10.1615/CritRevBiomedEng.v40.i5.1010.1615/CritRevBiomedEng.v40.i5.10 ↗
5. 10.1002/masy.20075070210.1002/masy.200750702 ↗
6. 10.1016/j.cossms.2003.09.01210.1016/j.cossms.2003.09.012 ↗
7. 10.1002/jbm.a.3307210.1002/jbm.a.33072 ↗
8. 10.1016/j.jmst.2013.03.00210.1016/j.jmst.2013.03.002 ↗
9. Patel PJ · Arch Ophthalmol · 2003 · 121 · 400
10. 10.1016/j.biomaterials.2009.11.05010.1016/j.biomaterials.2009.11.050 ↗
11. 10.1097/01.sap.0000199173.73610.bc10.1097/01.sap.0000199173.73610.bc ↗
12. 10.1177/088532821142919310.1177/0885328211429193 ↗
13. 10.1002/jbm.82005061110.1002/jbm.820050611 ↗
14. 10.1097/00003086-200106000-0001310.1097/00003086-200106000-00013 ↗
15. 10.1097/00003086-200106000-0001410.1097/00003086-200106000-00014 ↗
16. 10.1007/s00776-003-0664-410.1007/s00776-003-0664-4 ↗
17. 10.1007/BF0270370810.1007/BF02703708 ↗
18. 10.1016/j.niox.2009.02.00610.1016/j.niox.2009.02.006 ↗
19. 10.1016/S0736-0266(03)00104-910.1016/S0736-0266(03)00104-9 ↗
20. 10.1177/03913988050280081010.1177/039139880502800810 ↗
21. 10.1016/j.orthres.2003.10.00510.1016/j.orthres.2003.10.005 ↗
22. 10.1097/TA.0b013e318173e7c210.1097/TA.0b013e318173e7c2 ↗
23. 10.1097/TA.0b013e3181b28a8c10.1097/TA.0b013e3181b28a8c ↗
24. Duarić L · Coll Antropol · 2013 · 37 · 1291
25. 10.1016/j.actbio.2006.07.01210.1016/j.actbio.2006.07.012 ↗
26. 10.1007/s10856-008-3605-010.1007/s10856-008-3605-0 ↗
27. 10.1016/j.biomaterials.2006.01.01710.1016/j.biomaterials.2006.01.017 ↗
28. 10.1097/00003086-200106000-0000510.1097/00003086-200106000-00005 ↗
29. 10.1023/A:102547742146710.1023/A:1025477421467 ↗
30. 10.1002/jbmr.17110.1002/jbmr.171 ↗
31. 10.1016/j.actbio.2008.10.01710.1016/j.actbio.2008.10.017 ↗
32. 10.1016/j.jeurceramsoc.2012.10.01610.1016/j.jeurceramsoc.2012.10.016 ↗
33. Kuboki Y · Nano Biomedecine · 2009 · 1 · 85
34. Kuboki Y · Nano Biomed · 2010 · 2 · 107
35. 10.4012/dmj.2011-25910.4012/dmj.2011-259 ↗
36. 10.4012/dmj.2012-17110.4012/dmj.2012-171 ↗
37. 10.1016/j.biomaterials.2005.02.00210.1016/j.biomaterials.2005.02.002 ↗
38. 10.1016/j.cellsig.2009.10.01710.1016/j.cellsig.2009.10.017 ↗
39. 10.1210/me.2009-014310.1210/me.2009-0143 ↗
40. 10.1006/bbrc.2000.221010.1006/bbrc.2000.2210 ↗
41. 10.1016/j.exer.2007.11.01610.1016/j.exer.2007.11.016 ↗
42. 10.1074/jbc.M30801320010.1074/jbc.M308013200 ↗
43. 10.1016/j.bone.2003.11.01310.1016/j.bone.2003.11.013 ↗
44. 10.1016/j.biocel.2011.07.00810.1016/j.biocel.2011.07.008 ↗
45. 10.7863/ultra.33.5.86510.7863/ultra.33.5.865 ↗